CNBC Top News
중도 성향
산업/기업
Weight loss drug maker sinks 25% after new safety data spooks investors
While the experimental drug met its key targets, analysts are concerned over the commercial opportunity due to side effects.
CNBC · "DRUG" · 총 7건
필터 보기현재 지수
50.0
0 = 부정 우세
50 = 중립
100 = 긍정 우세
최근 7일 기준 225건을 분석한 결과, 뉴스 심리지수는 50.0(균형)입니다. 긍정 0건(0.0%)·중립 225건(100.0%)·부정 0건(0.0%)이며, 중립 비중이 뚜렷하게 높습니다. 성향 지수는 종합 0.0(중도 균형)입니다.
While the experimental drug met its key targets, analysts are concerned over the commercial opportunity due to side effects.
AstraZeneca CEO Pascal Soriot said AI is helping the company develop medicines faster and make smarter decisions throughout the research process.
Novo's approach to global launches will be guided by patient demand and the strength of healthcare and telehealth infrastructure, the drugmaker said.
Shares of French biotech Abivax tumbled 32% after it reported fresh data on its lead asset.
An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a late-stage trial, according to data released Sunday.
President Donald Trump is trying to fast-track research into psychedelics as treatments, creating new opportunities and risks.
CVS will add Zepbound coverage on Oct. 1, and start covering Lilly's newly approved Foundayo pill on June 1.